GSK1324726A
CAS: 1300031-52-0
Ref. 3D-ACC03152
| 2mg | 186.00 € | ||
| 5mg | 349.00 € | ||
| 10mg | 466.00 € | ||
| 25mg | 833.00 € | ||
| 50mg | 1,254.00 € |
Product Information
GSK1324726A is a small-molecule drug that can be used to treat cancer. It inhibits the HDAC enzyme, which is required for transcriptional repression of genes involved in tumorigenesis. GSK1324726A has been shown to inhibit the expression of suppressor genes and promote apoptosis in myeloid leukemia cells. This drug also potently inhibits HIV replication in vitro and has shown promising results in clinical studies involving patients with AIDS. GSK1324726A binds to bromodomain proteins, which are domains found on histone proteins that bind to acetylated lysine residues on DNA. These domains are known for their ability to regulate gene expression by binding to acetylated lysine residues on histone proteins and blocking transcriptional activation.
Chemical properties
Technical inquiry about: 3D-ACC03152 GSK1324726A
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
